Evidence map›Paper›PMID 42192870›Full record

ArticleCancers2026

Differential Protumoral Mechanisms Induced by CAFs in Cervical Cancer Cells Occur Independently of 17β-Estradiol Stimulation.

Jonathan René García-Bernal, Luis Javier Reséndiz-Castillo, Marcela Guadalupe Martínez-Barajas, Carlos Daniel Díaz-Palomera, Adrián Ramírez-de-Arellano, Alejandra Natali Vega-Magaña, Lesly Jazmin Bueno-Urquiza, Luis Reneé González-Lucano, Marcela Peña-Rodríguez, Julio César Villegas-Pineda and 1 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jonathan René García-BernalInstituto de Investigación en Cáncer e Infecciones, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0001-6251-8882
Luis Javier Reséndiz-CastilloInstituto de Investigación en Cáncer e Infecciones, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0009-0001-9478-2837
Marcela Guadalupe Martínez-BarajasInstituto de Investigación en Cáncer e Infecciones, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0001-7985-337X
Carlos Daniel Díaz-PalomeraInstituto de Investigación en Cáncer e Infecciones, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0002-2363-0318
Adrián Ramírez-de-ArellanoInstituto de Investigación en Cáncer e Infecciones, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0002-6743-1054
Alejandra Natali Vega-MagañaInstituto de Investigación en Cáncer e Infecciones, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0003-4749-2498
Lesly Jazmin Bueno-UrquizaInstituto de Investigación en Cáncer e Infecciones, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0002-9444-8695
Luis Reneé González-LucanoEscuela de Ciencias de la Salud y Medicina, Instituto Tecnológico y de Estudios Superiores de Monterrey, Campus Guadalajara, Zapopan 45138, Jalisco, Mexico.ORCID 0000-0002-9435-7283
Marcela Peña-RodríguezInstituto de Investigación en Cáncer e Infecciones, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
Julio César Villegas-PinedaInstituto de Investigación en Cáncer e Infecciones, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0003-0015-9444
Ana Laura Pereira-SuárezInstituto de Investigación en Cáncer e Infecciones, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.

Funding

Universidad de Guadalajara PIN 2024-V
6 · The paper itself

Abstract

backgroundE2 is fundamental to the onset and progression of CC. CAFs are the most abundant stromal population in the tumor microenvironment. CAFs have been shown to promote protumoral effects in CC cell lines; however, the effects of E2-stimulated CAFs remain to be explored.

objectivesThis study aimed to evaluate whether E2-stimulated CAFs modify the behavior of SiHa and HeLa tumor cells, including their metabolism, ROS production, migration, apoptosis, and gene expression.

methodsCharacterization and estrogen receptor expression in primary CAF cultures were evaluated by immunofluorescence. Supernatants from non-stimulated and E2-stimulated CAFs were used to culture CC cells, and mitochondrial metabolism was measured by MTT, ROS production by H2DCFDA, migration using the wound-healing assay, apoptosis by Annexin V assay, and gene expression by next-generation RNA-seq.

resultsStimulation of CC cells with CAFs' supernatants demonstrated that it influences tumor cells in different ways. In SiHa cells, the metabolic shift was supported by decreased mitochondrial metabolism, increased ROS production, and enhanced gene enrichment for glycolysis and hypoxia responses. On the other hand, in HeLa cells, CAFs enhanced migration and gene enrichment in KRAS signaling, epithelial-mesenchymal transition, and the proinflammatory response, via enrichment of the IL6/JAK/STAT3 signaling pathway, along with the overexpression of cytokines such as IFN-γ, IL-6, and IL-8.

conclusionsCAFs exert protumoral effects by promoting a metabolic shift in SiHa cells or enhancing migration and cytokine secretion in HeLa cells; these effects are independent of E2 stimulation in CAFs.

Indexed as

cancer-associated fibroblastscervical cancerestradiolmetabolismmigrationpro-tumoral effect

Identifiers

PMID42192870
PMCPMC13204976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.